Oxidation of Amino Acids in Proteins and Peptides
The modifi cation of amino acids in proteins and peptides by oxidative processes plays a major
role in the development of disease and in aging (Halliwell and Gutteridge, 1989, 1990; Kim
et al., 1985; Tabor and Richardson, 1987; Stadtman, 1992). Tissue damage through free radi-
cal oxidation is known to cause various cancers, neurological degenerative conditions, pulmo-
nary problems, infl ammation, cardiovascular disease, and a host of other problems. Oxidation
of protein structures can alter activity, inhibit normal protein interactions, modify amino acid
side chains, cleave peptide bonds, and even cause crosslinks to form between proteins.
Due to their abundance in cells relative to other biological molecules, proteins are one of
the primary targets of oxidation in vivo. However, sometimes oxidation reactions involving
proteins and peptides are thought of solely as the creation of disulfi des from thiols on cysteine
residues. This is certainly an important form of oxidation that can affect protein structure
and function or even cause problems relevant to bioconjugation reactions. The presence of an
accessible free thiol on a protein in an aqueous solution can be highly unstable to rapid oxida-
tion unless precautions are taken to prevent disulfi de formation. Dissolved oxygen and other
potentially catalytic components, such as certain metal salts, quickly can result in disulfi des
being formed within a protein or between different protein molecules.
From a broader perspective, protein oxidation can result in covalent modifi cation at many
sites other than just at cysteine thiols. The earliest reports on protein oxidation date from the
fi rst decade of the twentieth century, but it took many more years to characterize these reac-
tions and their products (Dakin, 1906).
The signifi cance of protein oxidation became paramount with the advent of recombinant
protein biologics used as human therapeutics. Careful characterization of protein stability is
essential to maintaining the effi cacy of protein pharmaceuticals. If even a single side chain
amino acid residue becomes oxidized, then a protein therapeutic may not have the same activ-
ity in vivo as the unmodifi ed protein.
Oxidation of proteins can result from exposure to oxidative species from many sources: reac-
tive oxygen intermediates caused by metabolic reactions within cells (mitochondrial electron
transport function and certain enzymes, such as oxidases, peroxidases, and P-450 enzymes),
from the by-products of oxidative stress reactions in cells (Sayre et al., 2001), or through the
presence of strongly oxidizing compounds within a solution—all of these can contribute to
selective damage or modifi cation to protein structures. Some examples of chemical agents that
oxidatively can modify proteins include hydrogen peroxide (H
2
O
2
) and other peroxy com-
pounds, such as perborate and peroxycarbonate; hydroperoxyl radical (
HO
2
); superoxide anion
(
O
2
); singlet oxygen (
1
O
2
); hydroxyl radical (
·
OH), periodate (IO
4
); metal salts in the pres-
ence of oxygen species, such as those of iron (Fe
3
and Fe
2
) and copper (Cu
2
); ozone (O
3
);
peroxynitrite (ONOO
); Hypobromous acid (HOBr); hypochlorous acid (HOCl); performic
acid (HC(O)OOH); trichloromethylperoxyl radical (CCl
3
OO
·
); under the right conditions
metal-chelating compounds, such as porphyrins, texaphyrins, and FeBABE; and gamma radia-
tion and UV light. For additional information see Winterbourn and Kettle (2000); Baynes and
Thorpe (2000); Greenacre and Ischiropoulos (2001); Halliwell and Gutteridge (1989, 1990);
Stadtman (1992).
Singlet oxygen (
1
O
2
) differs from the predominant oxygen molecule in that O
2
is in the
ground state or triplet state and its outer two unshared electrons have parallel spins (some-
times designated
3
O
2
), which is nearly unreactive toward other molecules, while singlet oxygen
1. Modifi cation of Amino acids, Peptides, and Proteins 23